The U.S. Food and Drug Administration approved the first at-home brain stimulation device for major depressive disorder in December 2025. Nine months later, a systematic review and meta-analysis in JMIR Mental Health reports that the benefit of home-based transcranial direct current stimulation is small, and small enough to vanish when a single trial is removed […]
The U.S. Food and Drug Administration approved the first at-home brain stimulation device for major depressive disorder in December 2025. Nine months later, a systematic review and meta-analysis in JMIR Mental Health reports that the benefit of home-based transcranial direct current stimulation is small, and small enough to vanish when a single trial is removed […]
